KLK4 and angioedema: If no prophylaxis is chosen because of low risk of inducing angioedema, then AERx's (pdC1INH, rhC1INH, kallikrein inhibitor, bradykinin b2 receptor antagonist) should be immediately available and should be used as early in a swelling event as possible.